Canada markets closed

Rigel Pharmaceuticals, Inc. (RIGL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.2000+0.0500 (+4.35%)
At close: 04:00PM EDT
1.2200 +0.02 (+1.67%)
After hours: 07:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 210.49M
Enterprise Value 214.13M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.79
Price/Book (mrq)N/A
Enterprise Value/Revenue 1.83
Enterprise Value/EBITDA -12.61

Trading Information

Stock Price History

Beta (5Y Monthly) 0.98
52-Week Change 3-3.36%
S&P500 52-Week Change 322.38%
52 Week High 31.9600
52 Week Low 30.7100
50-Day Moving Average 31.3194
200-Day Moving Average 31.1806

Share Statistics

Avg Vol (3 month) 31.51M
Avg Vol (10 day) 31.92M
Shares Outstanding 5175.4M
Implied Shares Outstanding 6175.4M
Float 8146.96M
% Held by Insiders 12.11%
% Held by Institutions 161.33%
Shares Short (Apr 15, 2024) 45.17M
Short Ratio (Apr 15, 2024) 43.31
Short % of Float (Apr 15, 2024) 43.01%
Short % of Shares Outstanding (Apr 15, 2024) 42.95%
Shares Short (prior month Mar 15, 2024) 44.94M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:9
Last Split Date 3Jun 25, 2003

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -21.67%
Operating Margin (ttm)5.23%

Management Effectiveness

Return on Assets (ttm)-10.73%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)115.78M
Revenue Per Share (ttm)0.67
Quarterly Revenue Growth (yoy)-27.60%
Gross Profit (ttm)N/A
EBITDA -20.35M
Net Income Avi to Common (ttm)-25.09M
Diluted EPS (ttm)-0.1400
Quarterly Earnings Growth (yoy)-47.40%

Balance Sheet

Total Cash (mrq)56.93M
Total Cash Per Share (mrq)0.32
Total Debt (mrq)104.17M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.86
Book Value Per Share (mrq)-0.16

Cash Flow Statement

Operating Cash Flow (ttm)-5.74M
Levered Free Cash Flow (ttm)-25.82M